Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVR118 in Anorectic Patients With Advanced Malignancies
NCT00765466Phase 2Terminated
- Sponsor
- McGill University
- Start
- Oct 2007
- Primary completion
- May 2010
- Modality
- Peptides, Nucleic Acid Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of EOM613 in anorexia nervosa (AN), sponsored by McGill University. Started Oct 2007; status: terminated.
02
Drugs
EOM613
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT00765466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00765466.